Platforms & Programs

Our research and technology portfolio span therapeutic discovery, bioprocess development and clinical research.

Virtual models for intervention prioritisation

Computational modelling of aged biological systems to prioritise interventions before expensive experimental validation.

What it integrates
Molecular, cellular and phenotypic data across ageing-related biological states.

What it enables
Ranking of candidate interventions, uncertainty-aware prediction and selection of the most informative experiments for validation.

Flagship Platform

GEROTWIN
Design clinical trials around real patient populations

Analyses trial eligibility criteria to show which requirements exclude patients before a protocol is finalised.

ImmunoCensus

Therapeutic Programs

Technology Platforms

HostBridge
Adaptive AI for bioprocess development

Host-adaptive modelling for cell-culture media, feeding strategies and experiment prioritisation with explicit uncertainty.

Lysosomal Repair — Parkinson’s Disease
A preclinical discovery program investigating pharmacological modulation of VPS13C-dependent lysosomal repair.